Aethlon Med Inc.
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 19 institutions reported holding Aethlon Med Inc. in their 13F filings, up 2 from Q2 2025. 8 opened new positions and 6 sold out. The largest holders were Ikarian Capital, LLC ($115K), HRT Financial LP ($97K) and Citadel Advisors ($71K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aethlon Med Inc.
- CUSIP
- 00808Y505
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $262K |
| Exits | 6 | $278K |
All 13F filers, Q2 2025 → Q3 2025: 352,865 shares bought and 232,924 shares sold, net +119,941 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Ikarian Capital, LLC | 0.02% | No change | 153,659 | $115K |
| HRT Financial LP | 0.00% | New | 130,601 | $97K |
| Citadel Advisors | 0.00% | New | 95,084 | $71K |
| Renaissance Technologies | 0.00% | New | 46,000 | $34K |
| Scientech Research LLC | 0.01% | New | 25,988 | $19K |
| Two Sigma Investments, LP | 0.00% | New | 20,270 | $15K |
| XTX Topco Ltd | 0.00% | New | 15,492 | $12K |
| Two Sigma Securities, LLC | 0.00% | New | 14,682 | $11K |
| Geode Capital Management, LLC | 0.00% | No change | 13,468 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +323.2% | 2,992 | $2K |
| Citigroup Inc. | 0.00% | New | 2,463 | $2K |
| Group One Trading LLC | 0.00% | No change | 151 | $113 |
| BlackRock, Inc. | 0.00% | Reduce -89.8% | 94 | $71 |
| Wells Fargo & Company | 0.00% | No change | 26 | $19 |
| Bank of America Corp. | 0.00% | Reduce -50.0% | 21 | $16 |
| Osaic Holdings, Inc. | 0.00% | No change | 7 | $12 |
| Morgan Stanley | 0.00% | Reduce -97.2% | 9 | $7 |
| Danske Bank A/S | 0.00% | No change | 3 | $2 |
| Bartlett & Co. Wealth Management LLC | 0.00% | No change | 3 | $2 |
"% of holder's portfolio" is AETHLON MED INC's weight in each manager's 13F, not the share of Aethlon Med Inc. the manager owns.